ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Review Article



An overview on clinical studies of Morus species with bioactivities of compounds providing supporting evidence

Eric Wei Chiang Chan.



Abstract
Download PDF Post

Morus of the family Moraceae is a small plant genus having 19 species worldwide. Among the Morus species, M. alba (MA), M. indica, M. nigra, and M. rubra are economically important. Of these species, the medicinal values of the whole plant, leaf, fruit, twig, and root of MA are the most well-known. Most noteworthy are the anti-diabetic properties of MA. In this review, 23 clinical studies on anti-diabetic properties (5 in Japan) and 9 clinical studies on other pharmacological properties (4 in Thailand) of Morus species are described. The latter includes hypolipidemic, cognitive enhancement, coronary heart disease attenuation, anti-obesity, and climacteric improvement. Further studies on the molecular mechanisms of mulberry compounds, and their safety, distribution, absorption, metabolism, and excretion are needed.

Key words: Morus alba, M. indica, M. nigra, mulberry, anti-diabetic, 1‐deoxynojirimycin







Bibliomed Article Statistics

14
16
17
20
37
41
17
25
31
17
12
13
R
E
A
D
S

20

21

21

14

13

24

13

8

11

15

14

2
D
O
W
N
L
O
A
D
S
010203040506070809101112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.